Medications screened for Alzheimer's treatment New York - Arab Today Drugs used for hypertension or insomnia may also help reduce the development of amyloid plaques, which is linked to Alzheimer's, US researchers say. Dr Giulio Maria Pasinetti of the Mount Sinai Medical Centre and a research team used a computer algorithm to screen 1,600 commercially available medications to assess their impact on the brain accumulation of beta-amyloid, a protein abnormally accumulated in the brain of Alzheimer's disease. The study, published in the journal PLoS One, found currently available medications prescribed for conditions such as hypertension, depression and insomnia were found to block or to enhance the accumulation of beta-amyloid, the component of amyloid plaques. Pasinetti and colleagues administered the drugs in mice that were genetically engineered to develop the amyloid plaques associated with Alzheimer's disease. After six months of treatment with blood pressure medicines, amyloid plaques and neurodegeneration were significantly reduced in the mice. "One very exciting finding of our study is that Carvedilol, already approved for treatment of hypertension, might immediately become a promising drug for the treatment of Alzheimer's as well," Pasinetti said in a statement. However, the findings must be verified in human-safety studies that examine the effects of the drugs independent of the original indication, Pasinetti said.
GMT 12:06 2018 Thursday ,13 December
Blue light in smartphones linked to blindness and some cancersGMT 11:56 2018 Friday ,30 November
Congo Ebola outbreak becomes second-worst in history, IRC saysGMT 17:52 2018 Sunday ,25 November
Russian medical team provides services to citizen in Talbiseh town in HomsGMT 11:28 2018 Thursday ,15 November
Cameroon strives to curb maternal and infant mortality in restive Anglophone regionsGMT 15:36 2018 Tuesday ,30 October
China’s invitation to pool efforts in finding cure for cancer and AIDSGMT 17:19 2018 Monday ,22 October
New campaign launched in Cairo to raise awareness of migrainesGMT 13:36 2018 Friday ,19 October
Egypt elected as member in joint coordination council of WHO programmeGMT 11:51 2018 Wednesday ,17 October
Syria, ICRC sign two MoUs on treatment diabetes and LeishmaniasisMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor